Age: 93.0
Sex: M
Vaccine: COVID19
Symptoms: Musculoskeletal disorder, Product availability issue, Product dose omission issue
Clinical narrative: Chest pain; Gallbladder with stones; Unable to walk on walker; admitted to the rehab facility to get therapy for upper and lower extremities as LLT upper extremity disfunction; He was so weak from laying there at the hospital for 4 days; The time the facility has it in stock it will be two months after the first dose; The time the facility has it in stock it will be two months after the first dose; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of CHEST PAIN (Chest pain), CHOLELITHIASIS (Gallbladder with stones), GAIT INABILITY (Unable to walk on walker) and MUSCULOSKELETAL DISORDER (admitted to the rehab facility to get therapy for upper and lower extremities as LLT upper extremity disfunction) in a 93-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Dementia and Walker user.    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, the patient experienced PRODUCT AVAILABILITY ISSUE (The time the facility has it in stock it will be two months after the first dose). On an unknown date, the patient experienced CHEST PAIN (Chest pain) (seriousness criterion hospitalization), CHOLELITHIASIS (Gallbladder with stones) (seriousness criterion hospitalization), GAIT INABILITY (Unable to walk on walker) (seriousness criterion disability), MUSCULOSKELETAL DISORDER (admitted to the rehab facility to get therapy for upper and lower extremities as LLT upper extremity disfunction) (seriousness criterion disability), ASTHENIA (He was so weak from laying there at the hospital for 4 days) and PRODUCT DOSE OMISSION ISSUE (The time the facility has it in stock it will be two months after the first dose). The patient was hospitalized for 4 days due to CHEST PAIN and CHOLELITHIASIS. At the time of the report, CHEST PAIN (Chest pain), CHOLELITHIASIS (Gallbladder with stones), GAIT INABILITY (Unable to walk on walker), MUSCULOSKELETAL DISORDER (admitted to the rehab facility to get therapy for upper and lower extremities as LLT upper extremity disfunction) and ASTHENIA (He was so weak from laying there at the hospital for 4 days) outcome was unknown and PRODUCT AVAILABILITY ISSUE (The time the facility has it in stock it will be two months after the first dose) and PRODUCT DOSE OMISSION ISSUE (The time the facility has it in stock it will be two months after the first dose) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Computerised tomogram: abnormal (abnormal) Gallbladder with stones was found.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was provided. Treatment information mentioned therapy for upper and lower extremities. Patient's PCP mentioned that there may be a reoccurrence of gallbladder stones in the future.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.  More information about the events has been requested.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.  More information about the events has been requested.